CIZ1B takes a focused biomarker approach to early lung cancer detection by identifying a specific protein signal produced by lung cancer cells. Learn how this targeted strategy differs from DNA-based cancer blood tests and why earlier detection matters.

Lung cancer often develops without clear symptoms in its earliest stages, which is why awareness and early detection are so important. Learn about common risk factors, symptoms to watch for, recommended screening guidelines, and why finding lung cancer early can help save lives.

Emerging research indicates smoking history may affect lung cancer outcomes even within the same stage. Learn what this could mean for patients and clinicians, and why earlier detection remains critical.

Lung cancer is often linked to a mix of risk factors, some preventable and others environmental. Learn the leading causes, what you can do to reduce exposure, and when screening may be appropriate.

Lung cancer screening rates remain dangerously low, with fewer than one in five eligible adults getting screened. New national studies show how many lives could be saved through expanded screening and more accessible tools such as the CIZ1B biomarker blood test. This article breaks down the latest data and why early detection solutions are urgently needed.

While smoking remains the leading cause of lung cancer, tens of thousands of people who have never smoked are diagnosed each year. Learn about other risk factors—like radon, air pollution, and genetics—and how early detection can save lives.